4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-24-014164
Director sold 20,000 shares at $17.26 ($345,200)
- Director acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
USMAN NASSIM · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $6.93 | $138,600 | 21,636 | D |
| 2024-03-15 | Sale : show line 2 in the form 10b5-1 | −20,000 | $17.26 | $345,200 | 1,636 | D |
| Open-market sales · 20,000 sh · avg $17.26 · $345,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-15 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −20,000 | 321,652 | D |
Loading xslF345X05/form4.xml…